Schmidt LE et al. |
Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. |
2003 |
Transplantation |
pmid:12883193
|
Mentzer RM et al. |
Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. |
1998 |
Transplantation |
pmid:9448154
|
Ernst A et al. |
Lung abcess complicating Legionella micdadei pneumonia in an adult liver transplant recipient: case report and review. |
1998 |
Transplantation |
pmid:9448158
|
Méndez A et al. |
Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. |
2014 |
Transplantation |
pmid:24492423
|
Moss MC et al. |
Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? |
2014 |
Transplantation |
pmid:24492429
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Narayanan M et al. |
Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression. |
2013 |
Transplantation |
pmid:23423268
|
Reutzel-Selke A et al. |
Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. |
2003 |
Transplantation |
pmid:12811235
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Hsiau M et al. |
Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. |
2011 |
Transplantation |
pmid:21857278
|
Yates CJ et al. |
Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. |
2013 |
Transplantation |
pmid:23902993
|
Kitayama T et al. |
Facilitation of tacrolimus-induced heart-allograft acceptability by pretransplant host treatment with granulocyte colony-stimulating factor: interleukin-12-restricted suppression of intragraft monokine mRNA expression. |
2003 |
Transplantation |
pmid:12605126
|
Guo Z et al. |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. |
1997 |
Transplantation |
pmid:9075844
|
Ciancio G et al. |
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. |
1997 |
Transplantation |
pmid:9075856
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Starzl TE et al. |
Hepatotrophic effects of FK506 in dogs. |
1991 |
Transplantation |
pmid:1702912
|
Camirand G et al. |
Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. |
2001 |
Transplantation |
pmid:11468532
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. |
2002 |
Transplantation |
pmid:12490779
|
Ahsan N et al. |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. |
2001 |
Transplantation |
pmid:11477347
|
Ho ET et al. |
Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. |
2013 |
Transplantation |
pmid:23542469
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Veroux M et al. |
Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications. |
2012 |
Transplantation |
pmid:22298033
|
Roelen DL et al. |
Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506. |
1993 |
Transplantation |
pmid:7687397
|
MacDonald AS |
Management strategies for nephrotoxicity. |
2000 |
Transplantation |
pmid:10910262
|
Kessler L et al. |
Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. |
2006 |
Transplantation |
pmid:16495816
|
Moffatt SD and Metcalfe SM |
Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade. |
2000 |
Transplantation |
pmid:10836388
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10836393
|
Meiser BM |
The best dosing for initial tacrolimus application is trough level adapted! |
2005 |
Transplantation |
pmid:15714162
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Garton T |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1. |
2002 |
Transplantation |
pmid:12352898
|
Ochiai T et al. |
Studies of the effects of FK506 on renal allografting in the beagle dog. |
1987 |
Transplantation |
pmid:2447688
|
Ochiai T et al. |
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. |
1987 |
Transplantation |
pmid:2447689
|
Peng Y et al. |
Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. |
2013 |
Transplantation |
pmid:23263506
|
Katz IA et al. |
Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. |
1991 |
Transplantation |
pmid:1716801
|
Hricik DE et al. |
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2003 |
Transplantation |
pmid:14508357
|
Chan L et al. |
Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients. |
2010 |
Transplantation |
pmid:20517177
|
Hodak SP et al. |
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. |
1998 |
Transplantation |
pmid:9734501
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|